JP2023524600A5 - - Google Patents
Info
- Publication number
- JP2023524600A5 JP2023524600A5 JP2022567867A JP2022567867A JP2023524600A5 JP 2023524600 A5 JP2023524600 A5 JP 2023524600A5 JP 2022567867 A JP2022567867 A JP 2022567867A JP 2022567867 A JP2022567867 A JP 2022567867A JP 2023524600 A5 JP2023524600 A5 JP 2023524600A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- independently
- case
- alkyl
- structural part
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026013992A JP2026090326A (ja) | 2020-05-08 | 2026-01-30 | Akt3モジュレーター |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063021981P | 2020-05-08 | 2020-05-08 | |
| US63/021,981 | 2020-05-08 | ||
| US202063121000P | 2020-12-03 | 2020-12-03 | |
| US63/121,000 | 2020-12-03 | ||
| PCT/US2021/031297 WO2021226458A1 (en) | 2020-05-08 | 2021-05-07 | Akt3 modulators |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026013992A Division JP2026090326A (ja) | 2020-05-08 | 2026-01-30 | Akt3モジュレーター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524600A JP2023524600A (ja) | 2023-06-12 |
| JP2023524600A5 true JP2023524600A5 (cg-RX-API-DMAC10.html) | 2024-04-23 |
| JP7874551B2 JP7874551B2 (ja) | 2026-06-16 |
Family
ID=78468458
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567867A Active JP7874551B2 (ja) | 2020-05-08 | 2021-05-07 | Akt3モジュレーター |
| JP2026013992A Pending JP2026090326A (ja) | 2020-05-08 | 2026-01-30 | Akt3モジュレーター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026013992A Pending JP2026090326A (ja) | 2020-05-08 | 2026-01-30 | Akt3モジュレーター |
Country Status (12)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021212111A1 (en) * | 2020-04-17 | 2021-10-21 | Augusta University Research Institute, Inc. | Compositions and methods for treating leukemia |
| WO2023064493A1 (en) * | 2021-10-13 | 2023-04-20 | Clear Creek Bio, Inc. | Compounds and methods for treating coronaviruses |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1158266C (zh) * | 1998-10-01 | 2004-07-21 | 阿斯特拉曾尼卡有限公司 | 化合物 |
| US7067532B2 (en) * | 2000-11-02 | 2006-06-27 | Astrazeneca | Substituted quinolines as antitumor agents |
| US7320989B2 (en) * | 2003-02-28 | 2008-01-22 | Encysive Pharmaceuticals, Inc. | Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
| MX2009006543A (es) * | 2006-12-20 | 2009-06-26 | Amgen Inc | Compuestos heterociclicos y su uso en el tratamiento de la inflamacion, angiogenesis y cancer. |
| WO2008140895A1 (en) | 2007-04-20 | 2008-11-20 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| US7790746B2 (en) * | 2007-10-12 | 2010-09-07 | Supergen, Inc. | Quinoline derivatives for modulating DNA methylation |
| EP2398797B1 (en) | 2009-02-17 | 2013-11-06 | Boehringer Ingelheim International GmbH | Pyrimido[5,4-d]pyrimidine derivatives for the inhibition of tyrosine kinases |
| KR101106050B1 (ko) * | 2009-03-25 | 2012-01-18 | 한국과학기술연구원 | 아미노퀴놀린 화합물, 이의 제조 방법 및 이를 함유하는 의약 조성물 |
| KR101271223B1 (ko) * | 2011-01-27 | 2013-06-07 | 한국과학기술연구원 | 아미노피리미딘 유도체 및 이를 포함하는 세포외 신호조절 키나제의 제해제 |
| US10292978B2 (en) * | 2016-01-15 | 2019-05-21 | Augusta University Research Institute, Inc. | Specific Akt3 inhibitor and uses thereof |
| US10342868B2 (en) | 2016-01-15 | 2019-07-09 | Augusta University Research Institute, Inc. | Methods and compositions for inhibiting Akt3 |
| KR102537985B1 (ko) * | 2016-09-12 | 2023-05-30 | 인테그랄 헬스 인코퍼레이티드 | Gpr120 조정제로서 유용한 단환형 화합물 |
| EP3678666B1 (en) | 2017-09-07 | 2025-07-09 | Augusta University Research Institute, Inc. | Specific akt3 activator and uses thereof |
-
2021
- 2021-05-07 AU AU2021267930A patent/AU2021267930A1/en active Pending
- 2021-05-07 KR KR1020227042311A patent/KR20230022457A/ko active Pending
- 2021-05-07 MX MX2022014021A patent/MX2022014021A/es unknown
- 2021-05-07 EP EP21800645.0A patent/EP4146212A4/en active Pending
- 2021-05-07 US US17/923,779 patent/US20230219927A1/en active Pending
- 2021-05-07 BR BR112022022551A patent/BR112022022551A2/pt unknown
- 2021-05-07 IL IL297600A patent/IL297600A/en unknown
- 2021-05-07 PH PH1/2022/553016A patent/PH12022553016A1/en unknown
- 2021-05-07 WO PCT/US2021/031297 patent/WO2021226458A1/en not_active Ceased
- 2021-05-07 JP JP2022567867A patent/JP7874551B2/ja active Active
- 2021-05-07 CN CN202180046175.4A patent/CN115996721A/zh active Pending
- 2021-05-07 CA CA3182012A patent/CA3182012A1/en active Pending
-
2026
- 2026-01-30 JP JP2026013992A patent/JP2026090326A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023525757A5 (cg-RX-API-DMAC10.html) | ||
| AU2023201399B2 (en) | Modulators of the integrated stress pathway | |
| AU2018360855B2 (en) | Modulators of the integrated stress pathway | |
| AU2018358157B2 (en) | Modulators of the integrated stress pathway | |
| JP7307057B2 (ja) | 統合的ストレス経路の調節剤 | |
| JP2023524596A5 (cg-RX-API-DMAC10.html) | ||
| US20230144871A1 (en) | Modulators of the integrated stress pathway | |
| CA2972014A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| JP2021523112A5 (cg-RX-API-DMAC10.html) | ||
| HUP0301213A2 (hu) | Ciklin dependens kinázok amino-tiazol inhibitorai, ezeket tartalmazó gyógyszerkészítmények, előállításuk és alkalmazásuk | |
| CA2643177A1 (en) | Multi-cyclic compounds for treating cancer | |
| PH12021552760A1 (en) | 3-amino-4h-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of mrgx2 | |
| CZ297907B6 (cs) | Aminothiazolové deriváty a farmaceutické kompozice s jejich obsahem | |
| RU2011108024A (ru) | 3-азабицикло(3.1.0) гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов | |
| JP2010528021A5 (cg-RX-API-DMAC10.html) | ||
| JP2024541995A5 (cg-RX-API-DMAC10.html) | ||
| JP2017532360A5 (cg-RX-API-DMAC10.html) | ||
| JP2024540107A5 (cg-RX-API-DMAC10.html) | ||
| KR20090055562A (ko) | 오로라 a 선택적 억제 작용을 갖는 신규한 아미노피리딘 유도체 | |
| JP2022511477A5 (cg-RX-API-DMAC10.html) | ||
| JP2023525756A5 (cg-RX-API-DMAC10.html) | ||
| TWI544920B (zh) | N-羥基-4-{2-[3-(n,n-二甲基胺基甲基)苯並呋喃-2-基羰基胺基]乙氧基}苯甲醯胺之新穎投藥法 | |
| JP2023554391A5 (cg-RX-API-DMAC10.html) | ||
| Duran et al. | Synthesis of 2-[4, 5-dimethyl-1-(phenylamino)-1 H-imidazol-2-ylthio]-N-(thiazole-2-yl) acetamide derivatives and their anticancer activities | |
| JP2024541994A5 (cg-RX-API-DMAC10.html) |